1. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (1st August 2020) Authors: Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (5th March 2020) Authors: Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials. (6th October 2020) Authors: Bieber, T.; Thyssen, J.P.; Reich, K.; Simpson, E.L.; Katoh, N.; Torrelo, A.; De Bruin‐Weller, M.; Thaci, D.; Bissonnette, R.; Gooderham, M.; Weisman, J.; Nunes, F.; Brinker, D.; Issa, M.; Holzwarth, K.; Gamalo, M.; Riedl, E.; Janes, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗